BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 26063761)

  • 1. Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.
    Miguez A; García-Díaz Barriga G; Brito V; Straccia M; Giralt A; Ginés S; Canals JM; Alberch J
    Hum Mol Genet; 2015 Sep; 24(17):4958-70. PubMed ID: 26063761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Downregulation of p75
    Suelves N; Miguez A; López-Benito S; Barriga GG; Giralt A; Alvarez-Periel E; Arévalo JC; Alberch J; Ginés S; Brito V
    Mol Neurobiol; 2019 Feb; 56(2):935-953. PubMed ID: 29804232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 EP2 activation reduces memory decline in R6/1 mouse model of Huntington's disease by the induction of BDNF-dependent synaptic plasticity.
    Anglada-Huguet M; Vidal-Sancho L; Giralt A; García-Díaz Barriga G; Xifró X; Alberch J
    Neurobiol Dis; 2016 Nov; 95():22-34. PubMed ID: 26369879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Enhances Hippocampal Synaptic Plasticity and Improves Memory Performance in Huntington's Disease.
    Cabezas-Llobet N; Vidal-Sancho L; Masana M; Fournier A; Alberch J; Vaudry D; Xifró X
    Mol Neurobiol; 2018 Nov; 55(11):8263-8277. PubMed ID: 29526016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
    Ma Q; Yang J; Li T; Milner TA; Hempstead BL
    Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p75NTR in Huntington's disease: beyond the basal ganglia.
    Brito V; Ginés S
    Oncotarget; 2016 Jan; 7(1):1-2. PubMed ID: 26700963
    [No Abstract]   [Full Text] [Related]  

  • 7. 7,8-dihydroxyflavone ameliorates cognitive and motor deficits in a Huntington's disease mouse model through specific activation of the PLCγ1 pathway.
    García-Díaz Barriga G; Giralt A; Anglada-Huguet M; Gaja-Capdevila N; Orlandi JG; Soriano J; Canals JM; Alberch J
    Hum Mol Genet; 2017 Aug; 26(16):3144-3160. PubMed ID: 28541476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies.
    Brito V; Puigdellívol M; Giralt A; del Toro D; Alberch J; Ginés S
    Cell Death Dis; 2013 Apr; 4(4):e595. PubMed ID: 23598407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotrophin receptor p75(NTR) mediates Huntington's disease-associated synaptic and memory dysfunction.
    Brito V; Giralt A; Enriquez-Barreto L; Puigdellívol M; Suelves N; Zamora-Moratalla A; Ballesteros JJ; Martín ED; Dominguez-Iturza N; Morales M; Alberch J; Ginés S
    J Clin Invest; 2014 Oct; 124(10):4411-28. PubMed ID: 25180603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain.
    Ginés S; Bosch M; Marco S; Gavaldà N; Díaz-Hernández M; Lucas JJ; Canals JM; Alberch J
    Eur J Neurosci; 2006 Feb; 23(3):649-58. PubMed ID: 16487146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of AMPA receptor surface diffusion restores hippocampal plasticity and memory in Huntington's disease models.
    Zhang H; Zhang C; Vincent J; Zala D; Benstaali C; Sainlos M; Grillo-Bosch D; Daburon S; Coussen F; Cho Y; David DJ; Saudou F; Humeau Y; Choquet D
    Nat Commun; 2018 Oct; 9(1):4272. PubMed ID: 30323233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p75 Neurotrophin Receptor Is an Essential Mediator of Impairments in Hippocampal-Dependent Associative Plasticity and Memory Induced by Sleep Deprivation.
    Wong LW; Tann JY; Ibanez CF; Sajikumar S
    J Neurosci; 2019 Jul; 39(28):5452-5465. PubMed ID: 31085607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease.
    Hsiao HY; Chen YC; Chen HM; Tu PH; Chern Y
    Hum Mol Genet; 2013 May; 22(9):1826-42. PubMed ID: 23372043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A small molecule TrkB ligand reduces motor impairment and neuropathology in R6/2 and BACHD mouse models of Huntington's disease.
    Simmons DA; Belichenko NP; Yang T; Condon C; Monbureau M; Shamloo M; Jing D; Massa SM; Longo FM
    J Neurosci; 2013 Nov; 33(48):18712-27. PubMed ID: 24285878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
    Kartalou GI; Salgueiro-Pereira AR; Endres T; Lesnikova A; Casarotto P; Pousinha P; Delanoe K; Edelmann E; Castrén E; Gottmann K; Marie H; Lessmann V
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes.
    Tran C; Heng B; Teo JD; Humphrey SJ; Qi Y; Couttas TA; Stefen H; Brettle M; Fath T; Guillemin GJ; Don AS
    J Neurochem; 2020 Apr; 153(2):173-188. PubMed ID: 31742704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct Visualisation of Abnormal Dendritic Spine Morphology in the Hippocampus of the R6/2 Transgenic Mouse Model of Huntington's Disease.
    Bulley SJ; Drew CJ; Morton AJ
    J Huntingtons Dis; 2012; 1(2):267-73. PubMed ID: 25063335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fingolimod (FTY720) attenuates social deficits, learning and memory impairments, neuronal loss and neuroinflammation in the rat model of autism.
    Wu H; Wang X; Gao J; Liang S; Hao Y; Sun C; Xia W; Cao Y; Wu L
    Life Sci; 2017 Mar; 173():43-54. PubMed ID: 28161158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models.
    Li W; Silva HB; Real J; Wang YM; Rial D; Li P; Payen MP; Zhou Y; Muller CE; Tomé AR; Cunha RA; Chen JF
    Neurobiol Dis; 2015 Jul; 79():70-80. PubMed ID: 25892655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice.
    Zajac MS; Pang TY; Wong N; Weinrich B; Leang LS; Craig JM; Saffery R; Hannan AJ
    Hippocampus; 2010 May; 20(5):621-36. PubMed ID: 19499586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.